Nuravax, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau (NCT07142278) | Nuravax, Inc. | 2025-11-01 |
| Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine (NCT06831812) | Nuravax, Inc. | 2024-06-12 |
Track Nuravax, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.